Related Experiment Video
Updated: Jun 10, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation
Fengxiang Wei1, Yanyun Xie, Lijian Tao
1Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Abstract:
The MEK-ERK pathway plays a role in DNA damage response (DDR). This has been thoroughly studied by modulating MEK activation. However, much less has been done to directly examine the contributions of ERK1 and ERK2 kinases to DDR. Etoposide induces G2/M arrest in a variety of cell lines, including MCF7 cells. DNA damage-induced G2/M arrest depends on the activation of the protein kinase ataxia-telangiectasia mutated (ATM). ATM subsequently activates CHK2 by phosphorylating CHK2 threonine 68 (T68) and CHK2 inactivates CDC25C via phosphorylation of its serine 216 (S216), resulting in G2/M arrest. To determine the contribution of ERK1 and ERK2 to etoposide-induced G2/M arrest, we individually knocked-down ERK1 and ERK2 in MCF7 cells using specific small interfering RNA (siRNA). Knockdown of either kinases significantly reduced ATM activation in response to etoposide treatment, and thereby attenuated phosphorylation of the ATM substrates, including the S139 of H2AX (gammaH2AX), p53 S15, and CHK2 T68. Consistent with these observations, knockdown of either ERK1 or ERK2 reduced etoposide-induced CDC25C S216 phosphorylation and significantly compromised etoposide-induced G2/M arrest in MCF7 cells. Taken together, we demonstrated that both ERK1 and ERK2 kinases play a role in etoposide-induced G2/M arrest by facilitating activation of the ATM pathway. These observations suggest that a cellular threshold level of ERK kinase activity is required for the proper checkpoint activation in MCF7 cells.
Insights
Both ERK1 and ERK2 kinases are crucial for DNA damage response, facilitating ATM pathway activation to induce G2/M arrest after etoposide treatment in MCF7 cells.
Area of Science:
- Cellular Biology
- Molecular Oncology
- DNA Damage Response
Background:
- The MEK-ERK pathway is implicated in DNA damage response (DDR), but the specific roles of ERK1 and ERK2 kinases remain underexplored.
- Etoposide triggers G2/M cell cycle arrest, a process dependent on ATM kinase activation.
Purpose of the Study:
- To investigate the direct contributions of ERK1 and ERK2 to etoposide-induced G2/M arrest.
- To elucidate the mechanism by which ERK1 and ERK2 influence the DNA damage response pathway.
Main Methods:
- Individual knockdown of ERK1 and ERK2 in MCF7 cells using small interfering RNA (siRNA).
- Assessment of ATM activation and phosphorylation of its substrates (H2AX, p53, CHK2) following etoposide treatment.
- Evaluation of CDC25C phosphorylation and cell cycle progression.
Main Results:
- Knockdown of ERK1 or ERK2 significantly reduced ATM activation and subsequent phosphorylation of ATM substrates (gammaH2AX, p53 S15, CHK2 T68) upon etoposide exposure.
- Reduced phosphorylation of CDC25C at S216 was observed in cells with ERK1 or ERK2 knockdown.
- Both ERK1 and ERK2 knockdown compromised etoposide-induced G2/M arrest, indicating their essential role in this process.
Conclusions:
- ERK1 and ERK2 kinases are essential for etoposide-induced G2/M arrest by facilitating ATM pathway activation.
- A cellular threshold of ERK kinase activity is necessary for proper checkpoint activation in response to DNA damage.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Negative Regulator Molecules
Mitogens and the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

